Individuals with weakened immune systems will now be able to receive a third dose of approved COVID-19 vaccines to boost their protection against the new coronavirus disease, the US Federal Drug Administration (FDA) has announced.
“The country has entered another new wave of pandemics, and the FDA is aware of the fact that immunocompromised people are at particular risk of developing a severe form of the disease,” said Janet Woodcock, the FDA's transitional head.
In the US, they have so far received emergency licenses and are administering the Moderna, Pfizer / BioNTech (two-dose) and Johnson & Johnson (single-dose) vaccines.
Some other countries, notably Israel, Germany and Chile, have already started or are planning to start giving a third dose of vaccine to the most vulnerable groups of the population as the more contagious Delta variant of the new coronavirus raises the risk of a recurrence of the health crisis. .
These countries defy the World Health Organization's call for a moratorium on third-dose doses until at least the end of September so that larger quantities of vaccines can be distributed to countries where the immunization campaign has not progressed.
The scientific community, meanwhile, remains divided over the value of the booster, or booster, third dose of COVID-19 vaccine to those who do not have comorbidities or are immunosuppressed.
His cases in the US have recently returned to the highest level in the last six months, which is attributed to the Delta variant.
ΑΠΕ-ΜΠΕ
